Latest News

Triple therapy revs up immune system against common brain tumor

A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report. Mice with implanted, mouse-derived glioblastoma cells lived an average of 67 days after the triple therapy, compared with mice that lasted 24 days when they received only the two immunotherapies.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • BPA exposure linked to autism spectrum disorder, study reports

  • BPA exposure linked to autism spectrum disorder

  • One step closer to defeating Alzheimer's disease

  • Cerebral blood flow as a possible marker for concussion outcomes

  • Survey of teen dating violence among US high school students

  • Minors easily able to purchase electronic cigarettes online

  • Scientists crack piece of neural code for learning, memory

  • Low sugar uptake in brain appears to exacerbate Alzheimer's disease

  • New assessment tool can predict successful teachers

  • Heart valve repair significantly improves emotional wellbeing in patients with mitral regurgitation

  •